Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow-to-Debt Ratio
Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow-to-debt ratio. Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Cash Flow-to-Debt Ratio of 0.23x as of December 2024, meaning its operating cash flow of CN¥47.07 Million could theoretically repay 0% of its total liabilities (CN¥200.84 Million) in one year. Check 301258 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Cash flow-to-debt ratio of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. Historical debt coverage capacity for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Check Suzhou Fushilai Pharmaceutical Co. Ltd. earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow-to-Debt Ratio by Year (2019–2024)
Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Suzhou Fushilai Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.23x | CN¥47.07 Million | CN¥200.84 Million | ▼ -57.8% |
| 2023 | 0.56x | CN¥94.77 Million | CN¥170.45 Million | ▼ -22.1% |
| 2022 | 0.71x | CN¥151.19 Million | CN¥211.75 Million | ▼ -18.7% |
| 2021 | 0.88x | CN¥199.73 Million | CN¥227.47 Million | ▼ -12.8% |
| 2020 | 1.01x | CN¥166.85 Million | CN¥165.61 Million | ▲ +13.4% |
| 2019 | 0.89x | CN¥150.55 Million | CN¥169.48 Million | — |